Biointron is excited to announce our participation in World ADC USA 2025, a leading event dedicated to accelerating the development of antibody-drug conjugates (ADCs). Taking place in San Diego, CA, from November 3-6, 2025, this conference brings together industry experts, researchers, and innovators to explore the latest advancements in ADC technology, clinical progress, and manufacturing solutions.
As ADCs continue to transform targeted therapeutics, Biointron is committed to advancing antibody engineering technologies that enhance ADC efficacy, safety, and manufacturability. Our expertise in high-quality recombinant antibody production enables the development of optimized ADC candidates for improved therapeutic outcomes.
Join us at this premier event as we contribute to shaping the future of ADC therapeutics. Stay tuned for more details on our participation, and we invite researchers and industry leaders to connect with us to discuss the next generation of antibody-drug conjugates.
For more details about the event, please visit the World ADC US 2025 website [https://worldadc-usa.com/]
Time: November 3-6, 2025
Location: San Diego, CA
Booth: #TBD
